Literature DB >> 5958957

Imidazoles. II. 5(or 4)-(Monosubstituted triazeno)imidazole-4(or 5)-carboxamides.

Y F Shealy, C A Krauth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5958957     DOI： 10.1021/jm00319a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  4 in total

1.  Clinical pharmacokinetics of high-dose DTIC.

Authors:  J M Buesa; E Urréchaga
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth.

Authors:  Yulian P Ramirez; Ann C Mladek; Roger M Phillips; Mikko Gynther; Jarkko Rautio; Alonzo H Ross; Richard T Wheelhouse; Jann N Sakaria
Journal:  Mol Cancer Ther       Date:  2014-10-28       Impact factor: 6.261

3.  Synthesis and quantitative structure-activity relationship of imidazotetrazine prodrugs with activity independent of O6-methylguanine-DNA-methyltransferase, DNA mismatch repair, and p53.

Authors:  Dimitrios Pletsas; Elrashied A E Garelnabi; Li Li; Roger M Phillips; Richard T Wheelhouse
Journal:  J Med Chem       Date:  2013-08-16       Impact factor: 7.446

4.  Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

Authors:  B J Foster; D R Newell; J Carmichael; A L Harris; L A Gumbrell; M Jones; P M Goodard; A H Calvert
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.